» Articles » PMID: 21460860

Recent Topics Related to Testosterone Deficiency Syndrome in Japan

Overview
Journal Asian J Androl
Specialty Urology
Date 2011 Apr 5
PMID 21460860
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Androgens, the levels of which decrease with ageing, play many physiological roles in various organs. Testosterone deficiency syndrome (TDS) has received widespread attention in the last several years. First-line treatment for TDS should be testosterone replacement therapy (TRT), which is reported to improve several TDS symptoms. Recently, a clinical practice manual for TDS was written and published by a collaborative team from the Japanese Urological Association and the Japanese Society for the Study of the Aging Male to recommend standard procedures for the diagnosis, treatment, prevention and monitoring of adverse reactions to TRT and for post-treatment assessment. In this manual, intramuscular injection of testosterone enanthate or human chorionic gonadotropin and the testosterone gel 'Glowmin' were recommended as TRT. Currently, two topics related to TDS are being focused on in Japan: the relationship between TDS and metabolic syndrome and treatment options for eugonadal patients with TDS symptoms. In this review, the possibility of TRT for metabolic syndrome as well as the relationship between testosterone and adiponectin, which is a key molecule in metabolic syndrome, is discussed. Finally, the possibility of herbal medicines as a treatment option for patients with TDS is addressed, especially for eugonadal patients, because eugonadal men with TDS symptoms account for approximately 30% of the general population. The increase in the levels of several cytokines, such as IL-8, IL-13, interferon-γ and tumor necrosis factor-α, after herbal medicine treatment may be the reason for this efficacy.

Citing Articles

Efficacy of keishibukuryogan for hot flashes in prostate cancer patients receiving androgen deprivation therapy: a sub-analysis focusing on hormonal and cytokine levels.

Shigehara K, Izumi K, Nakashima K, Kawaguchi S, Nohara T, Kadono Y Transl Androl Urol. 2023; 12(8):1273-1282.

PMID: 37680217 PMC: 10481189. DOI: 10.21037/tau-23-121.


Efficacy and safety of keishibukuryogan, a traditional Japanese Kampo medicine, for hot flashes in prostate cancer patients receiving androgen deprivation therapy.

Shigehara K, Izumi K, Nakashima K, Kawaguchi S, Nohara T, Kadono Y Transl Androl Urol. 2021; 9(6):2533-2540.

PMID: 33457227 PMC: 7807326. DOI: 10.21037/tau-20-901.


Effects of Kamikihito and Unkei-to on Sleep Behavior of Wild Type and Parkinson Model in .

Ito K, Kawasaki H, Suzuki T, Takahara T, Ishida N Front Psychiatry. 2017; 8:132.

PMID: 28824465 PMC: 5534454. DOI: 10.3389/fpsyt.2017.00132.


Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment.

Huhtaniemi I Asian J Androl. 2014; 16(2):192-202.

PMID: 24407185 PMC: 3955328. DOI: 10.4103/1008-682X.122336.

References
1.
Jackson J, Riggs M, Spiekerman A . Testosterone deficiency as a risk factor for hip fractures in men: a case-control study. Am J Med Sci. 1992; 304(1):4-8. DOI: 10.1097/00000441-199207000-00003. View

2.
Baulieu E, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B . Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A. 2000; 97(8):4279-84. PMC: 18228. DOI: 10.1073/pnas.97.8.4279. View

3.
Yassin A, Saad F . Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only. J Sex Med. 2007; 4(2):497-501. DOI: 10.1111/j.1743-6109.2007.00442.x. View

4.
Schubert M, Minnemann T, Hubler D, Rouskova D, Christoph A, Oettel M . Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism. J Clin Endocrinol Metab. 2004; 89(11):5429-34. DOI: 10.1210/jc.2004-0897. View

5.
Kunelius P, Lukkarinen O, Hannuksela M, Itkonen O, Tapanainen J . The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study. J Clin Endocrinol Metab. 2002; 87(4):1467-72. DOI: 10.1210/jcem.87.4.8138. View